Jane Street’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Buy |
212,830
+64,795
| +44% | +$608K | ﹤0.01% | 2127 |
|
|
2025
Q1 | $1.05M | Sell |
148,035
-107,221
| -42% | -$762K | ﹤0.01% | 2994 |
|
|
2024
Q4 | $2.98M | Buy |
255,256
+19,129
| +8% | +$223K | ﹤0.01% | 1654 |
|
|
2024
Q3 | $4.85M | Sell |
236,127
-9,299
| -4% | -$191K | ﹤0.01% | 1359 |
|
|
2024
Q2 | $5.49M | Buy |
245,426
+151,594
| +162% | +$3.39M | ﹤0.01% | 1590 |
|
|
2024
Q1 | $2.58M | Sell |
93,832
-110,453
| -54% | -$3.04M | ﹤0.01% | 1994 |
|
|
2023
Q4 | $6.23M | Buy |
204,285
+116,308
| +132% | +$3.55M | ﹤0.01% | 1315 |
|
|
2023
Q3 | $2.78M | Sell |
87,977
-116,862
| -57% | -$3.7M | ﹤0.01% | 1876 |
|
|
2023
Q2 | $8.35M | Buy |
204,839
+156,638
| +325% | +$6.39M | ﹤0.01% | 1100 |
|
|
2023
Q1 | $1.8M | Sell |
48,201
-12,822
| -21% | -$478K | ﹤0.01% | 2171 |
|
|
2022
Q4 | $2.13M | Buy |
61,023
+30,092
| +97% | +$1.05M | ﹤0.01% | 1943 |
|
|
2022
Q3 | $1.73M | Sell |
30,931
-9,119
| -23% | -$510K | ﹤0.01% | 2228 |
|
|
2022
Q2 | $2.07M | Buy |
40,050
+18,503
| +86% | +$958K | ﹤0.01% | 1936 |
|
|
2022
Q1 | $1.57M | Sell |
21,547
-13,367
| -38% | -$971K | ﹤0.01% | 2416 |
|
|
2021
Q4 | $4.13M | Buy |
34,914
+15,153
| +77% | +$1.79M | ﹤0.01% | 1217 |
|
|
2021
Q3 | $2.65M | Sell |
19,761
-31,938
| -62% | -$4.28M | ﹤0.01% | 1537 |
|
|
2021
Q2 | $8.37M | Sell |
51,699
-6,578
| -11% | -$1.07M | ﹤0.01% | 632 |
|
|
2021
Q1 | $4.68M | Sell |
58,277
-47,034
| -45% | -$3.77M | ﹤0.01% | 864 |
|
|
2020
Q4 | $5.73M | Buy |
105,311
+73,549
| +232% | +$4M | ﹤0.01% | 643 |
|
|
2020
Q3 | $631K | Buy |
31,762
+20,584
| +184% | +$409K | ﹤0.01% | 2231 |
|
|
2020
Q2 | $235K | Buy |
+11,178
| New | +$235K | ﹤0.01% | 3288 |
|